Rectal cancer

References

• American Joint Committee on Cancer. Colon and rectum. In: Beahrs OH, Hensen DE, Hutter RV, et al, eds. Manual for staging of cancer. Philadelphia: Lippincott, 1988:75–80
   Google Scholar
• Miles WE. A method of performing abdominoperineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon. Lancet 1908;2(Dec 19): 1812–3
   Google Scholar
• Dixon CF. Surgical removal of lesions occurring in the sigmoid and rectosigmoid. Am J Surg 1939;46:12–7
   Google Scholar
• Quirke P, Durdey P, Dixon MF, et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection: histopathological study of lateral tumour spread and surgical excision. Lancet 1986;2(8514):996–9
   PubMed Web of Science ®Google Scholar
• Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986; 1(8496): 1479–82
   PubMed Web of Science ®Google Scholar
• Williams NS, Dixon MF, Johnston D. Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients' survival. Br J Surg 1983;70(3):150–4
   PubMed Web of Science ®Google Scholar
• Wolmark N, Fisher B. An analysis of survival and treatment failure following abdominoperineal and sphincter-saving resection in Dukes' B and C rectal carcinoma: a report of the NSABP clinical trials. National Surgical Adjuvant Breast and Bowel Project. Ann Surg 1986;204(4):480–9
   PubMed Web of Science ®Google Scholar
• Enker WE, Pilipshen SJ, Heilweil ML, et al. En bloc pelvic Iymphadenectomy and sphincter preservation in the surgical management of rectal cancer. Ann Suig 1986;203(4): 426–33
   PubMed Web of Science ®Google Scholar
• Hojo K, Vernava AM 3d, Sugihara K, et al. Preservation of urine voiding and sexual function after rectal cancer surgery. Dis Colon Rectum 1991;34(7):532–9
   PubMed Web of Science ®Google Scholar
• Stearns MW Jr, Sternberg SS, DeCosse JJ. Treatment alternatives: localized rectal cancer. Cancer 1984;54(11 Suppl):2691–4
   PubMedGoogle Scholar
• Cohen AM, Wood WC, Gunderson LL, et al. Pathological studies in rectal cancer. Cancer 1980;45(12):2965–8
   PubMed Web of Science ®Google Scholar
• Påhlman L, Glimelius B. Preor postoperative radiotherapy in rectal and rectosigmoid carcinoma: report from a randomized multicenter trial. Ann Surg 1990;211(2):187–95
   PubMed Web of Science ®Google Scholar
• Sischy B. The status of radiation therapy in the management of carcinoma of the rectum. Surg Annu 1990;22:215–33
   PubMedGoogle Scholar
• Buyse M, Zeleniuch-Jacquotte A, Chalmers TC. Adjuvant therapy of colorectal cancer: why we still don't know. JAMA 1988; 259(24):3571–8
   PubMed Web of Science ®Google Scholar
• Houghton JA, Maroda SJ Jr, Phillips JO, et al. Biochemical determinants of responsiveness to 5-fluorouracil and its derivatives in xenografts of human colorectal adenocarcinomas in mice. Cancer Res 1981;41(l):144–9
   PubMedGoogle Scholar
• Evans RM, Laskin JD, Hakala MT. Effet of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil. Cancer Res 1981;41 (9 Pt l):3288–95
   PubMed Web of Science ®Google Scholar
• Park JG, Collins JM, Gazdar AF, et al. Enhancement of fluorinated pyrimidine-induced cytotoxicity by leucovorin in human colorectal carcinoma cell lines. J Natl Cancer Inst 1988;80(19):1560–4
   PubMedGoogle Scholar
• Arbuck SG. 5-FU/leucovorin: biochemical modulation that works? Oncology 1987;1:61–71
   PubMedGoogle Scholar
• Petrelli N, Douglass HO Jr, Herrera L, et al. The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group. J Clin Oncol 1989;7(10):14l9–26 [erratum, J Clin Oncol 1990;8(1):185]
   Web of Science ®Google Scholar
• Poon MA, O'Connell MJ, Wieand HS, et al. Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer. J Clin Oncol 1991;9(11):1967–72
   PubMed Web of Science ®Google Scholar
• Erlichman C, Fine S, Wong A, et al. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. J Clin Oncol 1988;6(3):469–75
   PubMed Web of Science ®Google Scholar
• Valone FH, Friedman MA, Wittlinger PS, et al. Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group. J Clin Oncol 1989; 7(10):1427–36
   PubMed Web of Science ®Google Scholar
• Vietti T, Eggerding E Valeriote F. Combined effect of x radiation and 5-fluorouracil on survival of transplanted leukemic cells. J Natl Cancer Inst 1971;47(4):865–70
   PubMedGoogle Scholar
• Byfield JE, Calabro-Jones P, Klisak I, et al. Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or Ftorafur and X rays. Int J Radiar Oncol Biol Phys 1982;8(11): 1923–33
   PubMed Web of Science ®Google Scholar
• Gastrointestinal Tumor Study Group. Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 1985:312(23): 1465–72
   PubMed Web of Science ®Google Scholar
• Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991; 324(11):709–15
   PubMed Web of Science ®Google Scholar
• NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264(11):1444–50
   PubMed Web of Science ®Google Scholar
• Rosenthal SA, Yeung RS, Weese JL, et al. Conservative management of extensive low-lying rectal carcinomas with transanal local excision and combined preoperative and postoperative radiation therapy: a report of a phase I-II trial. Cancer 1992;69(2):335–41
   PubMed Web of Science ®Google Scholar
• Hildebrandt U, Feifel G. Preoperative staging of rectal cancer by intrarectal ultrasound. Dis Colon Rectum 1985;28(l):42–6
   PubMedGoogle Scholar
• Matsui O, Takashima T, Kadoya M, et al. Liver metastases from colorectal cancers: detection with CT during arterial portography. Radiology 1987;165(l):65–9
   PubMedGoogle Scholar
• Minsky BD, Cohen AM, Kemeny N, et al. Enhancement of radiation-induced down-staging of rectal cancer by fluorouracil and highdose leucovorin chemotherapy. J Clin Oncol 1992;10(l):79–84
   PubMedGoogle Scholar
• Windle R, Wood RF, Bell PR. The effect of levamisole on postoperative immunosuppression. Br J Surg 1979;66(7):507–9
   PubMed Web of Science ®Google Scholar
• Verhaegen H, DeCree J, DeCock W, et al. Levamisole therapy in patients with colorectal cancer. In: Terry WD, Rosenberg SA, eds. Immunotherapy of human cancer. New York: Elsevier (Excerpta Medica), 1982:225–9
   Google Scholar
• Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990;322(6):352–8
   PubMed Web of Science ®Google Scholar
• Windle R, Bell PR, Shaw D. Five year results of a randomized trial of adjuvant 5- fluorouracil and levamisole in colorectal cancer. Br J Surg 1987;74(7):569–72
   PubMed Web of Science ®Google Scholar
• Nabi HA, Doerr RJ. Radiolabeled monoclonal antibody imaging (immunoscintigraphy) of colorectal cancers: current status and future perspectives. Am J Surg 1992; 163(4):448–56
   PubMed Web of Science ®Google Scholar